Search Results - "Porter, Alyx"

Neurologic Complications of Cancer Treatment by Porter, Alyx B.

“…Advances in cancer treatment have led to extended survival and increased risk of neurologic complications in an aging population. This review summarizes…”
Get full text

Promoting Inclusive Cancer Care: Beyond Medical Interpreters by Thomas, Alex G, Porter, Alyx B

“…Opportunities exist to promote inclusive cancer care and clinical research to reduce disparity and achieve health equity. Through raising awareness of the…”
Get full text

Brain metastases from non-small cell lung cancer with EGFR or ALK mutations: A systematic review and meta-analysis of multidisciplinary approaches by Singh, Raj, Lehrer, Eric J., Ko, Stephen, Peterson, Jennifer, Lou, Yanyan, Porter, Alyx B., Kotecha, Rupesh, Brown, Paul D., Zaorsky, Nicholas G., Trifiletti, Daniel M.

“…•Meta-analysis of NSCLC patients with brain metastases with or without EGFR or ALK mutations.•1st meta-analysis examining patients with brain metastases from…”
Get full text

IDH-wild-type glioblastoma cell density and infiltration distribution influence on supramarginal resection and its impact on overall survival: a mathematical model by Tripathi, Shashwat, Vivas-Buitrago, Tito, Domingo, Ricardo A, Biase, Gaetano De, Brown, Desmond, Akinduro, Oluwaseun O, Ramos-Fresnedo, Andres, Sherman, Wendy, Gupta, Vivek, Middlebrooks, Erik H, Sabsevitz, David S, Porter, Alyx B, Uhm, Joon H, Bendok, Bernard R, Parney, Ian, Meyer, Fredric B, Chaichana, Kaisorn L, Swanson, Kristin R, Quiñones-Hinojosa, Alfredo

“…Recent studies have proposed resection of the T2 FLAIR hyperintensity beyond the T1 contrast enhancement (supramarginal resection [SMR]) for IDH-wild-type…”
Get full text

Treatment of Glioma in the 21st Century: An Exciting Decade of Postsurgical Treatment Advances in the Molecular Era by Uhm, Joon H., MD, Porter, Alyx B., MD

“…Abstract The past decade has brought about major changes in the way we classify and have begun to approach patients with high-grade glioma. As we trend toward…”
Get full text

Socioeconomic status and glioblastoma risk: a population-based analysis by Porter, Alyx B., Lachance, Daniel H., Johnson, Derek R.

“…Purpose: Socioeconomic status (SES) is associated with risk of various cancer types because of correlation between SES and causal factors or increased case…”
Get full text

Image-based metric of invasiveness predicts response to adjuvant temozolomide for primary glioblastoma by Massey, Susan Christine, White, Haylye, Whitmire, Paula, Doyle, Tatum, Johnston, Sandra K, Singleton, Kyle W, Jackson, Pamela R, Hawkins-Daarud, Andrea, Bendok, Bernard R, Porter, Alyx B, Vora, Sujay, Sarkaria, Jann N, Hu, Leland S, Mrugala, Maciej M, Swanson, Kristin R

“…Temozolomide (TMZ) has been the standard-of-care chemotherapy for glioblastoma (GBM) patients for more than a decade. Despite this long time in use,…”
Get full text

A population study of clinical trial accrual for women and minorities in neuro-oncology following the NIH Revitalization Act by Reihl, Sheantel J, Patil, Nirav, Morshed, Ramin A, Mehari, Mulki, Aabedi, Alexander, Chukwueke, Ugonma N, Porter, Alyx B, Fontil, Valy, Cioffi, Gino, Waite, Kristin, Kruchko, Carol, Ostrom, Quinn, Barnholtz-Sloan, Jill, Hervey-Jumper, Shawn L

“…Abstract Background The NIH Revitalization Act, implemented 29 years ago, set to improve the representation of women and minorities in clinical trials. In this…”
Get full text

Integrated molecular and multiparametric MRI mapping of high-grade glioma identifies regional biologic signatures by Hu, Leland S., D’Angelo, Fulvio, Weiskittel, Taylor M., Caruso, Francesca P., Fortin Ensign, Shannon P., Blomquist, Mylan R., Flick, Matthew J., Wang, Lujia, Sereduk, Christopher P., Meng-Lin, Kevin, De Leon, Gustavo, Nespodzany, Ashley, Urcuyo, Javier C., Gonzales, Ashlyn C, Curtin, Lee, Lewis, Erika M., Singleton, Kyle W., Dondlinger, Timothy, Anil, Aliya, Semmineh, Natenael B., Noviello, Teresa, Patel, Reyna A., Wang, Panwen, Wang, Junwen, Eschbacher, Jennifer M., Hawkins-Daarud, Andrea, Jackson, Pamela R., Grunfeld, Itamar S., Elrod, Christian, Mazza, Gina L., McGee, Sam C., Paulson, Lisa, Clark-Swanson, Kamala, Lassiter-Morris, Yvette, Smith, Kris A., Nakaji, Peter, Bendok, Bernard R., Zimmerman, Richard S., Krishna, Chandan, Patra, Devi P., Patel, Naresh P., Lyons, Mark, Neal, Matthew, Donev, Kliment, Mrugala, Maciej M., Porter, Alyx B., Beeman, Scott C., Jensen, Todd R., Schmainda, Kathleen M., Zhou, Yuxiang, Baxter, Leslie C., Plaisier, Christopher L., Li, Jing, Li, Hu, Lasorella, Anna, Quarles, C. Chad, Swanson, Kristin R., Ceccarelli, Michele, Iavarone, Antonio, Tran, Nhan L.

“…Sampling restrictions have hindered the comprehensive study of invasive non-enhancing (NE) high-grade glioma (HGG) cell populations driving tumor progression…”
Get full text

Image-localized biopsy mapping of brain tumor heterogeneity: A single-center study protocol by Urcuyo, Javier C, Curtin, Lee, Langworthy, Jazlynn M, De Leon, Gustavo, Anderies, Barrett, Singleton, Kyle W, Hawkins-Daarud, Andrea, Jackson, Pamela R, Bond, Kamila M, Ranjbar, Sara, Lassiter-Morris, Yvette, Clark-Swanson, Kamala R, Paulson, Lisa E, Sereduk, Chris, Mrugala, Maciej M, Porter, Alyx B, Baxter, Leslie, Salomao, Marcela, Donev, Kliment, Hudson, Miles, Meyer, Jenna, Zeeshan, Qazi, Sattur, Mithun, Patra, Devi P, Jones, Breck A, Rahme, Rudy J, Neal, Matthew T, Patel, Naresh, Kouloumberis, Pelagia, Turkmani, Ali H, Lyons, Mark, Krishna, Chandan, Zimmerman, Richard S, Bendok, Bernard R, Tran, Nhan L, Hu, Leland S, Swanson, Kristin R

“…Brain cancers pose a novel set of difficulties due to the limited accessibility of human brain tumor tissue. For this reason, clinical decision-making relies…”
Get full text

Predicting access to postoperative treatment after glioblastoma resection: an analysis of neighborhood-level disadvantage using the Area Deprivation Index (ADI) by Rivera Perla, Krissia M., Tang, Oliver Y., Durfey, Shayla N. M., Vivas-Buitrago, Tito, Sherman, Wendy J., Parney, Ian, Uhm, Joon H., Porter, Alyx B., Elinzano, Heinrich, Toms, Steven A., Quiñones-Hinojosa, Alfredo

“…Purpose Social determinants of health (SDoH)—socioeconomic and environmental factors—impact outcomes. The Area Deprivation Index (ADI), a composite of…”
Get full text

Defining interventions and metrics to improve diversity in CNS clinical trial participation: A SNO and RANO effort by Budhu, Joshua A, Chukwueke, Ugonma N, Jackson, Sadhana, Lee, Eudocia Q, McFaline-Figueroa, J Ricardo, Willmarth, Nicole, Dalmage, Mahalia, Kawachi, Ichiro, Arons, David, Chang, Susan M, Galanis, Evanthia, Hervey-Jumper, Shawn L, Wen, Patrick Y, Porter, Alyx B

“…Despite major strides in cancer research and therapy, these advances have not been equitable across race and ethnicity. Historically marginalized groups (HMG)…”
Get full text

The survival outcomes of molecular glioblastoma IDH-wildtype: a multicenter study by Ramos-Fresnedo, Andres, Pullen, Michael W., Perez-Vega, Carlos, Domingo, Ricardo A., Akinduro, Oluwaseun O., Almeida, Joao P., Suarez-Meade, Paola, Marenco-Hillembrand, Lina, Jentoft, Mark E., Bendok, Bernard R., Trifiletti, Daniel M., Chaichana, Kaisorn L., Porter, Alyx B., Quiñones-Hinojosa, Alfredo, Burns, Terence C., Kizilbash, Sani H., Middlebrooks, Erik H., Sherman, Wendy J.

“…Purpose Histological diagnosis of glioblastoma (GBM) was determined by the presence of necrosis or microvascular proliferation (histGBM). The 2021 WHO…”
Get full text

A broad perspective on evaluating bias in the neuro-oncology workplace by Kumthekar, Priya, Dunbar, Erin M, Peters, Katherine B, Brastianos, Priscilla K, Porter, Alyx B

Get full text

Mystery Case: Widespread plexiform neurofibromas in neurofibromatosis type 1: An uncommon cause of back pain by Grimsrud, Kate W, Porter, Alyx B

Get full text

A Journey Toward Gender Equity in Medicine by Porter, Alyx B., Noe, Katherine H., Tazelaar, Henry D., Saliba, Kara L., Kary, Tamara K., Pockaj, Barbara A., Menkosky, Paula E., Gray, Richard J., Rebecca, Alanna M.

Get full text

How much time do we have? Longitudinal perception of prognosis in newly-diagnosed high grade glioma patients and caregivers compared to clinicians by Sharma, Akanksha, Fruth, Briant, Barrera, Celina, Farfour, Hannah N., Mrugala, Maciej M., Edwin, Mark K., Sloan, Jeff A., Porter, Alyx B.

“…Purpose Discordant prognostic awareness (PA) can cause distress, impact goals of care and future planning, especially in patients with high grade glioma…”
Get full text

Uncertainty quantification in the radiogenomics modeling of EGFR amplification in glioblastoma by Hu, Leland S., Wang, Lujia, Hawkins-Daarud, Andrea, Eschbacher, Jennifer M., Singleton, Kyle W., Jackson, Pamela R., Clark-Swanson, Kamala, Sereduk, Christopher P., Peng, Sen, Wang, Panwen, Wang, Junwen, Baxter, Leslie C., Smith, Kris A., Mazza, Gina L., Stokes, Ashley M., Bendok, Bernard R., Zimmerman, Richard S., Krishna, Chandan, Porter, Alyx B., Mrugala, Maciej M., Hoxworth, Joseph M., Wu, Teresa, Tran, Nhan L., Swanson, Kristin R., Li, Jing

“…Radiogenomics uses machine-learning (ML) to directly connect the morphologic and physiological appearance of tumors on clinical imaging with underlying genomic…”
Get full text

Systemic Therapy for Melanoma Brain and Leptomeningeal Metastases by Sherman, Wendy J., Romiti, Edoardo, Michaelides, Loizos, Moniz-Garcia, Diogo, Chaichana, Kaisorn L., Quiñones-Hinojosa, Alfredo, Porter, Alyx B.

“…Opinion statement Melanoma has a high propensity to metastasize to the brain which portends a poorer prognosis. With advanced radiation techniques and targeted…”
Get full text

The impact of multiple lesions on progression-free survival of meningiomas: a 10-year multicenter experience by Ramos-Fresnedo, Andres, Domingo, Ricardo A, Sanchez-Garavito, Jesus E, Perez-Vega, Carlos, Akinduro, Oluwaseun O, Jentoft, Mark E, Vora, Sujay A, Brown, Paul D, Porter, Alyx B, Bendok, Bernard R, Link, Michael J, Middlebrooks, Erik H, Trifiletti, Daniel M, Chaichana, Kaisorn L, Quiñones-Hinojosa, Alfredo, Sherman, Wendy J

“…Multiple meningiomas (MMs) occur in as many as 18% of patients with meningioma, and data on progression-free survival (PFS) are scarce. The objective of this…”
Get full text